Skip to main content
. 2017 May 12;17:327. doi: 10.1186/s12885-017-3313-6

Fig. 1.

Fig. 1

Twenty-five days after the first application of ipilimumab/nivolumab combination therapy the patient reported paraesthesia and pain in the fingertips; a slight erythema is visible on the fingertip of digitus 4 of the left hand (a). Five days after the second course ipilimumab/nivolumab combination therapy, a violaceous erythema was observed on digitus 3 and 4 of the left hand (b). Paraesthesia and pain also deteriorated